IDH1 and central nervous system cancer: The effects of IDH1 and IDH2 mutations on α-ketoglutarate flux and accumulation of 2-hydroxyglutarate leading to altered intracellular signaling in glioma cells, have been extensively reviewed elsewhere (Waitkus et al., 2015).